227 related articles for article (PubMed ID: 16183236)
21. Ceramides inhibit phospholipase D-dependent insulin signaling in liver cells of old rats.
Babenko NA; Kharchenko VS
Biochemistry (Mosc); 2012 Feb; 77(2):180-6. PubMed ID: 22348478
[TBL] [Abstract][Full Text] [Related]
22. Effect of exercise duration on the key pathways of ceramide metabolism in rat skeletal muscles.
Błachnio-Zabielska A; Baranowski M; Zabielski P; Górski J
J Cell Biochem; 2008 Oct; 105(3):776-84. PubMed ID: 18680146
[TBL] [Abstract][Full Text] [Related]
23. Measurement of ceramide and sphingolipid metabolism in tumors: potential modulation of chemotherapy.
Modrak DE
Methods Mol Med; 2005; 111():183-94. PubMed ID: 15911980
[TBL] [Abstract][Full Text] [Related]
24. Partial hepatectomy activates production of the pro-mitotic intermediates of the sphingomyelin signal transduction pathway in the rat liver.
Zabielski P; Baranowski M; Zendzian-Piotrowska M; Blachnio A; Gorski J
Prostaglandins Other Lipid Mediat; 2007 Jun; 83(4):277-84. PubMed ID: 17499747
[TBL] [Abstract][Full Text] [Related]
25. Age-related changes in neutral sphingomyelin-specific phospholipase C activity in striatum, hippocampus, and frontal cortex: implication for sensitivity to stress and inflammation.
Crivello NA; Rosenberg IH; Dallal GE; Bielinski D; Joseph JA
Neurochem Int; 2005 Dec; 47(8):573-9. PubMed ID: 16140422
[TBL] [Abstract][Full Text] [Related]
26. Ceramide metabolite, not intact ceramide molecule, may be responsible for cellular toxicity.
Tserng KY; Griffin RL
Biochem J; 2004 Jun; 380(Pt 3):715-22. PubMed ID: 14998372
[TBL] [Abstract][Full Text] [Related]
27. Effect of melatonin administration on parameters related to oxidative damage in hepatocytes isolated from old Wistar rats.
Castillo C; Salazar V; Ariznavarreta C; Vara E; Tresguerres JA
J Pineal Res; 2005 May; 38(4):240-6. PubMed ID: 15813900
[TBL] [Abstract][Full Text] [Related]
28. Neutral sphingomyelinase-induced ceramide accumulation by oxidative stress during carbon tetrachloride intoxication.
Ichi I; Kamikawa C; Nakagawa T; Kobayashi K; Kataoka R; Nagata E; Kitamura Y; Nakazaki C; Matsura T; Kojo S
Toxicology; 2009 Jun; 261(1-2):33-40. PubMed ID: 19394401
[TBL] [Abstract][Full Text] [Related]
29. Sphingolipids in psychiatric disorders and pain syndromes.
Mühle C; Reichel M; Gulbins E; Kornhuber J
Handb Exp Pharmacol; 2013; (216):431-56. PubMed ID: 23563670
[TBL] [Abstract][Full Text] [Related]
30. Bezafibrate decreases growth stimulatory action of the sphingomyelin signaling pathway in regenerating rat liver.
Zabielski P; Baranowski M; Zendzian-Piotrowska M; Błachnio-Zabielska A; Górski J
Prostaglandins Other Lipid Mediat; 2008 Feb; 85(1-2):17-25. PubMed ID: 18024222
[TBL] [Abstract][Full Text] [Related]
31. Changes of sphingolipid species in the phenotype conversion from myofibroblasts to lipocytes in hepatic stellate cells.
Andrade CM; Trindade VM; Cardoso CC; Ziulkoski AL; Trugo LC; Guaragna RM; Borojevic R; Guma FC
J Cell Biochem; 2003 Feb; 88(3):533-44. PubMed ID: 12532329
[TBL] [Abstract][Full Text] [Related]
32. Pioglitazone induces de novo ceramide synthesis in the rat heart.
Baranowski M; Blachnio A; Zabielski P; Gorski J
Prostaglandins Other Lipid Mediat; 2007 Feb; 83(1-2):99-111. PubMed ID: 17259076
[TBL] [Abstract][Full Text] [Related]
33. Influence of biotransformation of luteolin, luteolin 7-O-glucoside, 3',4'-dihydroxyflavone and apigenin by cultured rat hepatocytes on antioxidative capacity and inhibition of EGF receptor tyrosine kinase activity.
Schlupper D; Giesa S; Gebhardt R
Planta Med; 2006 Jun; 72(7):596-603. PubMed ID: 16732514
[TBL] [Abstract][Full Text] [Related]
34. Effect of hypothyreosis on the content of ceramides in rat tissues.
Górska M; Dobrzyń A; Langfort J; Górski J
J Physiol Pharmacol; 2003 Mar; 54(1):89-97. PubMed ID: 12674221
[TBL] [Abstract][Full Text] [Related]
35. Dietary sphingolipids suppress a subset of preneoplastic rat liver lesions exhibiting high PTEN, low phospho-Akt and high levels of ceramide species.
Silins I; Högberg J; Stenius U
Food Chem Toxicol; 2006 Sep; 44(9):1552-61. PubMed ID: 16757079
[TBL] [Abstract][Full Text] [Related]
36. [Sphingolipid changes in rat cerebral cortex during focal ischemia--how does ceramide accumulate in an ischemic condition?].
Kubota M; Tomukai N; Kitahara S; Nakagomi T; Tamura A; Hisaki H; Shimasaki H; Ueta N
No To Shinkei; 1995 Aug; 47(8):756-61. PubMed ID: 7546920
[TBL] [Abstract][Full Text] [Related]
37. Sphingolipids of transplantable rat nephroma-RA.
Kandyba AG; Somova OG; Kozlov AM; Zubova ES; Dudnik LB; Alessenko AV; Shvetz VI; Dyatlovitskaya EV
Biochemistry (Mosc); 2000 Jun; 65(6):703-6. PubMed ID: 10887290
[TBL] [Abstract][Full Text] [Related]
38. Bradykinin increases ceramide and sphingosine content in human fibroblasts: possible involvement of glycosphingolipids.
Meacci E; Vasta V; Farnararo M; Bruni P
Biochem Biophys Res Commun; 1996 Apr; 221(1):1-7. PubMed ID: 8660316
[TBL] [Abstract][Full Text] [Related]
39. Anticancer compounds and sphingolipid metabolism in the colon.
Duan RD
In Vivo; 2005; 19(1):293-300. PubMed ID: 15796189
[TBL] [Abstract][Full Text] [Related]
40. Sphingolipid biosynthesis de novo by rat hepatocytes in culture. Ceramide and sphingomyelin are associated with, but not required for, very low density lipoprotein secretion.
Merrill AH; Lingrell S; Wang E; Nikolova-Karakashian M; Vales TR; Vance DE
J Biol Chem; 1995 Jun; 270(23):13834-41. PubMed ID: 7775441
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
